Types of Peptides: Scientific Classification & Biological Roles

Across human physiology, thousands of distinct peptide molecules carry out specialized biological functions. A peptide regulating glucose homeostasis in the pancreas has little in common with a peptide modulating synaptic transmission in the brain or an antimicrobial defense peptide on human skin [1].

To organize this vast diversity, biomedical science uses two primary classification axes: functional taxonomy (what the peptide does in vivo) and structural taxonomy (how the molecule is constructed chemically). Understanding both frameworks is vital for evaluating therapeutic potential, stability, and clinical evidence [2].

When organized by their physiological and signaling role in living organisms, peptides fall into four major classes [1]:

1. Peptide Hormones (Endocrine Signaling)
Synthesized in specialized endocrine glands and enteroendocrine cells, peptide hormones travel through systemic circulation to regulate whole-body metabolism, mineral balance, and reproductive cycles. Key examples include:

• Incretin Hormones: Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which amplify postprandial insulin release [3].
• Pancreatic Hormones: Glucagon (29 aa) and Somatostatin (14 or 28 aa), regulating fuel mobilization.
• Pituitary Hormones: Adrenocorticotropic hormone (ACTH, 39 aa), luteinizing hormone-releasing factor (GnRH, 10 aa), and oxytocin (9 aa).

2. Neuropeptides (Neurological Signaling)
Produced by central and peripheral neurons, neuropeptides act as neurotransmitters or neuromodulators with longer-lasting synaptic actions than classical small-molecule transmitters like glutamate or GABA. Examples include substance P (pain transmission), neuropeptide Y (NPY, appetite regulation), and endogenous opioid peptides (endorphins, enkephalins, dynorphins) [1].

3. Antimicrobial Peptides (AMPs / Host Defense)
Evolutionarily ancient effector molecules of innate immunity. AMPs are typically short (12–50 amino acids), net-positively charged (cationic), and structurally amphipathic. Rather than binding a specific protein receptor, they physically insert into the negatively charged phospholipid bilayers of bacterial membranes, creating toroidal pores that cause osmotic lysis [4]. Major human families include alpha- and beta-defensins and cathelicidin (LL-37).

4. Local Paracrine Modulators & Growth Factors
Peptides released locally into interstitial fluid to coordinate wound repair, angiogenesis, and cell differentiation, such as fibroblast growth factor fragments and vasoactive kinins (bradykinin, kallidin) [2].

Equally critical is the chemical architecture of the peptide molecule, which determines its stability, bioavailability, and receptor-binding conformation [2]:

1. Linear Unmodified Peptides: Straight chains of standard L-amino acids with free N-terminal amines and C-terminal carboxylates. Highly flexible, but rapidly cleared by circulating aminopeptidases and carboxypeptidases (e.g., native GLP-1, native secretin).

2. Cyclic & Disulfide-Constrained Peptides: Peptides containing covalent rings formed either by intramolecular disulfide bonds between cysteine residues (e.g., oxytocin, vasopressin) or by head-to-tail amide backbone cyclization (e.g., cyclosporine, circular plant cyclotides). Cyclization reduces conformational entropy and physically shields vulnerable bonds from proteolytic cleavage [5].

3. Bioactive Peptide Fragments (Matrikines): Short peptide segments liberated from larger parent proteins through regulated extracellular proteolysis. For example, GHK (glycyl-L-histidyl-L-lysine) is a tripeptide fragment liberated from alpha-2-macroglobulin and collagen that chelates copper (GHK-Cu) [2].

4. Conjugated & Lipidated Peptides: Engineered peptides covalently linked to non-peptide chemical moieties. In modern drug discovery, fatty diacids (such as C16 or C18 fatty acids) are acylated to lysine side chains, allowing the peptide to reversibly hitchhike on circulating human serum albumin. This shields the molecule from glomerular filtration and extends half-life by orders of magnitude (e.g., semaglutide, tirzepatide) [6].

Peptides are also distinguished by how they are generated and sourced [6]:

• Endogenous Peptides: Naturally produced by the human body’s genome and cellular translation machinery.
• Natural Product Peptides (Zoopharmacology & Phytochemistry): Peptides isolated from non-human organisms, particularly venomous animals (cone snails, scorpions, spiders, snakes) and plants. For example, exenatide was derived from the salivary venom of the Gila monster (Heloderma suspectum), and ziconotide was isolated from the cone snail Conus magus [2].
• Fully De Novo Synthetic Peptides: Compounds designed through computational structural biology or phage display libraries that possess no natural evolutionary precursor.

Because native peptides have short circulating lifespans, medicinal chemists utilize specialized structural modifications to create viable pharmaceutical medicines [6]:

• D-Amino Acid Substitution: Human proteases are stereospecific for natural L-amino acids. Substituting one or more positions with their mirror-image D-enantiomers prevents enzymatic recognition while preserving receptor binding.
• Non-Canonical Residues: Introducing unnatural amino acids, such as alpha-aminoisobutyric acid (Aib) at position 8 of semaglutide, directly blocks cleavage by dipeptidyl peptidase-4 (DPP-4) [3].
• C-Terminal Amidation & N-Terminal Acetylation: Capping the charged ends of the peptide with amide (-NH₂) or acetyl (Ac-) groups mimics natural hormonal processing and blocks exopeptidase digestion.
• PEGylation: Covalently attaching polyethylene glycol polymers to increase hydrodynamic volume and block renal clearance.